Financial Data and Key Metrics Changes - Net sales for Q4 were $389.2 million, a 2.2% decline from $397.9 million in the same quarter last year [26] - Same-store sales decreased by 6.8% on a 13-week basis compared to the same period in fiscal year 2024 [27] - Adjusted EBITDA for Q4 increased to $45.2 million from $43 million in Q4 2024 [31] - Net loss for Q4 was $162.8 million, or $17.54 per diluted share, compared to a net loss of $9.9 million, or $1.07 per diluted share in the prior year [30] - Full year 2025 sales were approximately $1.24 billion, down from $1.33 billion in 2024 [32] Business Line Data and Key Metrics Changes - Chemicals category sales were down approximately 7.1%, and equipment category sales were down 7.6% on a 13-week comparable basis [27] - The company experienced a net loss of over 160,000 residential customers, with a decline in residential traffic of 8.6% in 2025 [6][10] Market Data and Key Metrics Changes - The company noted a significant price-value challenge leading to market share loss [5] - The competitive pricing environment in Q4 was influenced by excess supply and aggressive pricing from competitors [80] Company Strategy and Development Direction - The company is focusing on cost optimization, cash and capital management, and improving the price-value equation [4][6] - Plans to close 80 to 90 underperforming stores, which will impact annual sales by approximately $25 million to $35 million but improve net EBITDA by $4 million to $10 million [17][34] - The company aims to enhance its customer value proposition through targeted marketing and improved pricing strategies [8][10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging macroeconomic environment and its impact on consumer spending [38] - The company expects to generate the majority of its sales and earnings in the second half of the year due to the seasonal nature of the industry [38] - For fiscal 2026, the company anticipates sales between $1.1 billion and $1.25 billion and adjusted EBITDA of $55 million to $75 million [39] Other Important Information - The company is implementing a comprehensive expense reduction initiative and renegotiating contracts with vendors and suppliers [35] - Inventory levels were reduced by $26 million year-over-year, with a focus on improving in-stock percentages on core SKUs [29][32] Q&A Session Summary Question: Are supplier partners supporting the turnaround efforts? - Management confirmed that vendor partners have been supportive, allowing for better inventory forecasts and improved in-stock positions [49][51] Question: How much of the EBITDA guide is expected to convert into free cash flow? - The midpoint of the EBITDA guide assumes free cash flow positivity for the year [53] Question: Where do you see the most opportunity in pricing? - The focus is on key value items, particularly in the chemicals category, with a strategy to remain competitive against specialty and big box retailers [60][61] Question: What is the impact of store closures on revenue? - The closures are expected to have a $25 million to $35 million impact on revenue, but the majority of the stores being closed were unprofitable [70][72] Question: What is the plan to regain lost customers? - The company plans to target lost customers with customized marketing efforts based on their previous purchasing behavior [74][76] Question: Can you comment on competitive dynamics in Q4? - Management noted aggressive pricing in the marketplace and the need to remain competitive, which has led to sequential improvements in performance [80]

Financial Data and Key Metrics Changes - Net sales for Q4 were $389.2 million, a decline of 2.2% from $397.9 million in the same quarter last year [26] - Same-store sales decreased by 6.8% on a 13-week basis compared to the same period in fiscal year 2024 [27] - Gross margin for Q4 increased to 38.6% from 36% in the prior year, driven by favorable vendor rebates and freight costs [29] - Net loss for Q4 was $162.8 million, or $17.54 per diluted share, compared to a net loss of $9.9 million, or $1.07 per diluted share in the same quarter last year [30] - Adjusted EBITDA for Q4 increased to $45.2 million from $43 million in Q4 2024 [31] - Full year 2025 sales were approximately $1.24 billion, down from $1.33 billion in 2024 [31] Business Line Data and Key Metrics Changes - Chemicals sales were down approximately 7.1%, and equipment sales were down 7.6% on a 13-week comparable basis [27] - The company experienced a net loss of over 160,000 residential customers, with a decline in residential traffic of 8.6% in 2025 [6][10] Market Data and Key Metrics Changes - The company noted a competitive pricing environment in Q4, which affected sales performance [80] - The company is focusing on improving its price-value perception to regain market share lost due to pricing challenges [6][10] Company Strategy and Development Direction - The company is implementing immediate actions to improve operations and accelerate financial profitability, including closing 80-90 underperforming stores [7][17] - A restructuring of field teams is underway to enhance customer relationships and drive growth [11] - The company is focusing on a customer-centric approach, enhancing its value proposition through targeted marketing and pricing strategies [12][44] - Plans to optimize inventory and reduce SKU counts by over 2,000 are in place to improve operational efficiency [20][37] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging macroeconomic environment and its impact on consumer spending, but expressed confidence in the company's strategic direction [38] - The company expects to generate the majority of its sales and earnings in the second half of the year, consistent with the seasonal nature of the industry [39] - Guidance for fiscal 2026 includes expected sales of $1.1 billion to $1.25 billion and adjusted EBITDA of $55 million to $75 million [39] Other Important Information - The company ended the fiscal year with no outstanding borrowings on its line of credit and $752 million of net long-term debt [32] - A $184 million impairment charge was recorded in Q4, primarily related to goodwill and the closure of underperforming stores [30] Q&A Session Summary Question: Are supplier partners supporting the turnaround efforts? - Management confirmed that vendor partners have been supportive, allowing for better inventory forecasts and improved in-stock positions [49][51] Question: What is the expected free cash flow conversion for this year? - The midpoint of the guidance assumes free cash flow positivity for the year [52] Question: Where do the most pricing opportunities lie? - The focus is on key value items, particularly in the chemicals category, with a strategy to remain competitive against other retailers [60] Question: What is the impact of store closures on revenue? - The closures are expected to impact annual sales by approximately $25-$35 million, but the majority of the stores being closed were unprofitable [70][72] Question: How does the company plan to regain lost customers? - Targeted marketing efforts will be employed to reach former customers, leveraging data from the Pool Perks Loyalty Program [74][76] Question: What are the competitive dynamics observed in Q4? - Management noted aggressive pricing in the marketplace and the need to remain competitive, which has led to sequential improvements in performance [80]

Financial Data and Key Metrics Changes - Total revenue for FY 2025 was just under $2.5 billion, slightly ahead of FY 2024, driven by a decline in the new car market but mitigated by strong performance in used cars, finance and insurance, and service [3][19] - EBITDA was just over $110 million, with underlying profit before tax of $22.3 million, in line with guidance [3][19] - Net debt decreased to $46.7 million, down $14 million from the previous year, with a net debt to property ratio of 20% [4][27] Business Line Data and Key Metrics Changes - Used vehicle sales increased by 14% to 9,702 units, offsetting declines in new car sales [20] - Service and parts revenue grew to $422 million, up 4% from the previous year [20] - New car margins decreased by 0.8 percentage points from 16.9% to 16.1%, but margins in other service lines remained favorable [22][25] Market Data and Key Metrics Changes - The new car market remains highly competitive with an influx of new brands, leading to margin pressures [9][29] - Chinese brands now represent around 20% of the company's brand portfolio, with significant consumer acceptance noted [6][70] Company Strategy and Development Direction - The company aims to be Australia's most valued automotive group, focusing on innovation, customer centricity, organic growth, and acquisitions [12][13] - Emphasis on improving efficiencies through technology, including automation and AI, to enhance customer service and operational performance [15][18] - The strategy includes a balanced approach to managing used cars, service, parts, and finance to mitigate risks associated with new car market fluctuations [10][29] Management's Comments on Operating Environment and Future Outlook - Management noted that the automotive industry is undergoing significant transformation, with a focus on adapting to new vehicle emission standards and increasing competition [8][9] - The outlook for FY 2026 includes expectations for continued growth in higher-margin service lines and a stable new car market [29][30] - Management expressed confidence in the company's ability to grow earnings and maintain a strong performance culture [30][33] Other Important Information - The company successfully reduced new vehicle inventory from $382 million to $351 million, reflecting disciplined inventory management [5] - A fully frank final dividend of $0.04 per share was declared, bringing the total dividend for the year to $0.56 per share [27][28] Q&A Session Summary Question: What drove the stronger used car sales performance? - Management highlighted the focus on acquiring the right level of stock and maximizing opportunities in used car sales [37][38] Question: How much of the OpEx improvement came from lower commissions? - A significant portion of the OpEx reduction was attributed to lower commissions, with expectations for continued cost savings in FY 2026 [40][42] Question: What is the business performance outlook for the first seven weeks of FY 2026? - Management indicated that gross margins have remained stable at 16.1%, with a slight increase in overall market activity [43][44] Question: Have gross margins found a sustainable base? - Management confirmed that margins have stabilized and are expected to remain consistent into FY 2026 [48][49] Question: What is the outlook for new vehicle sales and OEM responses? - Management noted that several OEMs are releasing new models, which should positively impact sales, with stable order rates observed [56][60] Question: Can you provide details on the new Chinese brands onboarded? - The company currently represents brands such as LDV, MG, and GWM, with positive market reception noted [67][70]

Financial Data and Key Metrics Changes - The company reported second quarter revenue of $182 million, reflecting a 15% increase year-over-year, with an 11% organic growth excluding acquisitions and currency effects, and a 17% organic non-COVID growth [26][27] - Adjusted income from operations was $22 million, up 8% year-over-year, with an adjusted operating margin of 12%, down 80 basis points from the previous year [30][31] - Adjusted fully diluted earnings per share for the second quarter were $0.37, down 6% year-over-year [32] Business Line Data and Key Metrics Changes - Chromatography revenue grew over 40%, driven by large-scale column demand from Pharma and Europe, while filtration revenue grew mid-teens excluding COVID [21][22] - Capital equipment revenue returned to growth in the high teens, with orders growing over 20% [12][22] - Consumable revenue and orders, excluding proteins, grew over 20% year-over-year, marking a record revenue quarter on a non-COVID basis [11][24] Market Data and Key Metrics Changes - North America represented 49% of total revenue, Europe 38%, and Asia Pacific 13%, with all regions growing in the mid-teens [27] - Orders from China rebounded to over 40% year-over-year, indicating a significant recovery [28][58] - Emerging biotech revenue grew in the high teens, although orders remained muted [10][60] Company Strategy and Development Direction - The company aims to be the global innovation leader in bioprocessing, focusing on differentiated data-driven solutions across therapeutic modalities [15][16] - Strategic investments are being made in manufacturing labor to serve customers better and preserve lead times [9] - The company plans to double its size in the medium term with modest M&A assumptions, while maintaining profitability and driving gross margin expansion [17][37] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about the business momentum, highlighting strong order trends and broad-based demand across the portfolio [8][10] - The company is focused on customer-centric innovation to enable clients to produce therapies more efficiently [10][16] - Despite macro challenges, the company believes it can deliver differentiated growth and outpace industry growth by 5% [17][73] Other Important Information - The company published its 2024 corporate sustainability report, highlighting a 25% reduction in waste generation [20] - The company has taken price actions to offset inflation, resulting in a slight benefit to 2025 revenue [19] Q&A Session Summary Question: Can you elaborate on the growth seen on the clinical trial side versus commercial campaigns? - Management noted very little pull forward in orders, except for a couple of million in China due to tariff uncertainties, and emphasized that the business is still more clinical than commercial [44][45] Question: Can you size your exposure to gene therapy? - Management indicated minimal incremental revenue expected from the gene therapy platform for the remainder of 2025, representing a 1% headwind versus prior guidance [48][49] Question: What are the trends in capital equipment and China? - Management expressed optimism about capital equipment performance, attributing it to differentiated systems and a strong funnel, while also noting a significant rebound in orders from China [56][58] Question: What is the outlook for new modalities? - Management acknowledged a muted outlook for new modalities in the second half but emphasized strong growth in other areas, compensating for the headwind from gene therapy [66][68] Question: What is the expected market growth? - Management estimates market growth to be between 8% to 12%, with confidence in achieving growth above market levels [72][74]

Financial Data and Key Metrics Changes - Sales for the second quarter were $177.1 million, down from $188.7 million in the prior year, reflecting a decline of 6% year over year [24] - Gross profit decreased to $43.9 million from $54.3 million, with gross margin dropping to 24.8% from 28.8% [24][25] - Adjusted EBITDA was reported at a loss of $36 million, aligning with guidance despite top-line softness [9][10] Business Line Data and Key Metrics Changes - Pro Pool sales were down 2%, while Residential Pool sales declined by 9%. Hot tub sales, however, increased by 4% year over year [8] - The conversion rate improved by 174 basis points year over year, with significant increases observed after water tests using proprietary technology [9][50] Market Data and Key Metrics Changes - The company experienced weaker foot traffic in February due to colder temperatures, impacting overall sales performance [8] - The introduction of Local Fulfillment Centers (LFCs) has begun to positively impact customer service and inventory management [10][11] Company Strategy and Development Direction - The company is focused on a transformation journey centered around customer centricity, convenience, and asset utilization, with a new pillar of cost optimization introduced [7][30] - Strategic initiatives include optimizing inventory, enhancing the Pro customer experience, and improving DIY omnichannel capabilities [10][14][15] - The launch of a new loyalty program, Pool Perks, aims to reward loyal customers and enhance engagement [17][18] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by weather conditions but expressed confidence in the team's ability to meet guidance for the remainder of the year [28][80] - The company is committed to reducing debt and improving working capital through inventory optimization and cost management strategies [26][30] Other Important Information - The company reduced inventory by 12% year over year, ending the quarter at $335.1 million [26] - A partnership with Uber for same-day delivery services is expected to enhance customer convenience and operational efficiency [22][75] Q&A Session Summary Question: Competitive landscape and comp sales performance - Management noted that weather impacted sales but expressed confidence in gaining market share, particularly in the Pro segment [35][39] Question: Pricing strategy related to tariffs - The company plans to implement pricing adjustments primarily to offset tariff impacts, which are estimated to be less than 1% of total sales [42][43] Question: Comp weakness and underlying fundamentals - Management indicated that weather was a significant factor in comp weakness, but improvements in conversion rates were encouraging [46][50] Question: Inventory purchases and defensive strategies - The company is focused on optimizing inventory while preparing for potential market challenges in the second half of 2025 [51][52] Question: Cost optimization and expense ratio - Management highlighted ongoing efforts to identify cost savings, particularly in indirect spend, while maintaining a focus on growth [56][58] Question: E-commerce and digitally initiated sales - The partnership with Uber was driven by customer demand for faster service, benefiting both Pro and DIY customers [72][74] Question: Top-line guidance and revenue seasonality - Management reiterated confidence in full-year sales outlook, emphasizing that a significant portion of sales is still expected in the upcoming months [79][81]

Financial Performance - Emerald Holding's Q1 2025 revenue reached $147.7 million, demonstrating a 10.7% year-over-year growth[10, 27] - Adjusted EBITDA for Q1 2025 was $53.6 million, a 34.7% increase compared to the previous year[10, 27] - The company reaffirmed its full-year 2025 revenue guidance, expecting between $450 million and $460 million[10, 35, 36] - Emerald also reaffirmed its full-year 2025 Adjusted EBITDA guidance, projecting between $120 million and $125 million[10, 35, 36] - Free cash flow for Q1 2025 was $10.8 million[27, 41] Capital Allocation - Emerald repurchased $8.8 million of its common stock in Q1 2025, at an average price of $4.33 per share[10, 27] - The Board of Directors authorized an additional $25 million for share repurchases through December 31, 2025[10] - A quarterly dividend of $0.015 per share was declared for the quarter ending June 30, 2025[10] Strategic Initiatives - Emerald received regulatory approval for the acquisition of This is Beyond, a luxury travel event business, expected to close soon[10] - Connections segment accounted for approximately 90% of FY 2024 revenue[11]

Emerald Holding, Inc. Fourth Quarter and Full Year 2024 March 14, 2025 Legal Disclaimer Forward-Looking Statements This presentation also includes certain non-GAAP financial measures. These non-GAAP financial measures are in addition to, and should not be considered as a substitute for or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles ("GAAP"). The non-GAAP measures included herein may be different from similarly titled non-GAAP measures u ...